Guess which ASX healthcare stock is rocketing 5% today (hint: not ResMed!)

This stock is outpacing the broader sector today.

| More on:
healthcare worker overseeing group of aged care residents at table

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX healthcare stocks are shining today and staging a recovery from the past week's sell-off.

At the time of writing, the S&P/ASX Healthcare Index (ASX: XHJ) is up more than 1% against the benchmark S&P/ASX 200 Index (ASX: XJO)'s 0.5% gain.

Regis Healthcare Ltd (ASX: REG) is an ASX healthcare stock that is on a roll today, surging 5% to fetch $4.36 per share at the time of writing.

Despite no market-sensitive announcements from the company, the stock is one of the top-performing healthcare names at the time of publication on Wednesday, according to CommSec data.

With many focused on health darlings like ResMed Inc (ASX: RMD), you don't want to miss the forest for the trees. There are plenty more names in the healthcare sector.

Let's dive into this lesser-known ASX healthcare stock.

ASX healthcare stock catching a bid

Regis Healthcare is one of Australia's largest aged care providers. The stock is up more than 78% in the past twelve months.

In May, Macquarie analysts rated the ASX healthcare stock a buy. According to my colleague James, the broker cited favourable recommendations from the Aged Care Taskforce as its reasoning.

These recommendations are aimed at supporting a sustainable and innovative aged care system, which bodes well for Regis' future growth, Macquarie says.

The anticipated increase in earnings through 2028 from the industry changes led Macquarie to lift its earnings estimates and set a price target of $5.50 on the ASX healthcare stock.

Financials also a talking point

Regis Healthcare's latest financial results are another talking point, in my opinion. For the first half of FY24, the company reported:

  • Revenue of $480.1 million, up 26% year on year
  • Pre-tax earnings of $52.1 million, a 16% increase compared to the previous period
  • Net profit of $16.3 million, up a staggering 527% from the same period last year

These underlying figures paint a positive picture of growth and profitability.

Whilst it operates in aged care, the ASX healthcare stock's management is rejuvenating the company's balance sheet.

For instance, the company's recent acquisition of CPSM has added five more aged care homes to its books.

This brings its total to 68 residences with 7,604 beds under management. In my view, this expansion has been a significant driver behind the ASX healthcare stock's gain over the past 12 months.

Foolish takeaway

Regis Healthcare is catching a strong bid on Wednesday despite no company-specific news.

With healthcare stocks in general staging a recovery today, it's not unlikely that investors saw an opportunity to buy a high-quality franchise with solid H1 FY24 financials.

It could also be speculation. Who's to truly know?

Past performance is no guarantee of future results, though. As always, conduct your own due diligence and consider chatting to a professional.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »